Jazz Pharmaceuticals Stock: What Analysts Are Saying About Its Future Price
Jazz Pharmaceuticals (NASDAQ: JAZZ) shares have surged 22% month-to-date after a series of bullish analyst upgrades—Morgan Stanley, UBS, and Piper Sandler—raised price targets to $307, $301, and $301, respectively, citing ... Read More